13F HOLDINGS REPORT
Sarissa Capital Management LP
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0000899140-24-001252
Total Value
$402.3M
Positions
10
Other Managers
0
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INNOVIVA INC | INVA | 7,277,000 | $140.5M | 34.93% |
| 2 | IRONWOOD PHARMACEUTICALS INC | IRWD | 16,390,000 | $67.5M | 16.78% |
| 3 | GILEAD SCIENCES INC | GILD | 763,333 | $64.0M | 15.91% |
| 4 | CYTOKINETICS INC | CYTK | 1,110,000 | $58.6M | 14.57% |
| 5 | NEUROCRINE BIOSCIENCES INC | NBIX | 410,483 | $47.3M | 11.76% |
| 6 | AMARIN CORP PLC | AMRN | 24,850,623 | $15.6M | 3.87% |
| 7 | BIOGEN INC | BIIB | 26,950 | $5.2M | 1.30% |
| 8 | LANTHEUS HLDGS INC | LNTH | 26,000 | $2.9M | 0.71% |
| 9 | VOR BIOPHARMA INC | VOR | 618,000 | $432,600 | 0.11% |
| 10 | REGULUS THERAPEUTICS INC | 75915K309 | 185,183 | $290,737 | 0.07% |